Leslie Carol Botha: “People with immune issues?” These are little girls and little boys at age 9 – hardly people. And how would their parent’s even know at that age if they have immune issues? Define immune issues. Someone with a history of autoimmune issues for one. This is not ruled out before a girl is vaccinated.
According to Wikipedia Immune Disorders are defined as such:
An immune disorder is a dysfunction of the immune system. These disorders can be characterized in several different ways:
- By the component(s) of the immune system affected
- By whether the immune system is overactive or underactive
- By whether the condition is congenital or acquired
According to the International Union of Immunological Societies, more than 150 primary immunodeficiency diseases (PIDs) have been characterized. However, the number of acquired immunodeficiencies exceeds the number of PIDs.
It has been suggested that most people have at least one primary immunodeficiency. Due to redundancies in the immune system, though, many of these are never detected.
Can you imagine how parents feel reading this study after getting their son’s and daughter’s vaccinated?
The HPV vaccine campaign is fraudulent (as well as some of the other information in this article) – and has cost tens if not hundreds of thousands of girls their lives. If they did not have an autoimmune condition before – they do now.
In addition – and this has been my battle cry – girls are getting vaccinated at menarche at the most fragile time of their lives. The neuro-endocrine-immune systems are fragile at this time. AND girls are getting vaccinated regardless of where they are in their menstrual cycle. If the are vaccinated during the paramenstrum ( premenstrual phase and menstruation), immunity is already compromised.
Now they are recommending that “people with immune issues” take HIV medication? Parent’s are you ready for this? How about supporting the immune system with nutrition?
Current HPV Vaccine May Not Help Some Women With Immune Problems
April 7, 2013
Women with HIV acquire cancer-causing forms of the human papillomavirus (HPV) that are not included in the current HPV vaccines Gardasil and Cervarix, according to new research from Fox Chase Cancer Center being presented at the AACR Annual Meeting 2013 on Sunday, April 7.
“People with issues in their immune system such as HIV will be at risk of acquiring HPV, as well — and the current vaccine may not fully protect them,” says study author Elizabeth Blackman, MPH, research specialist at Fox Chase.
Women who had been taking HIV medications for at least 4 years, however, were less likely to carry cancer-causing forms of HPV, suggesting that treating HIV may also protect women from the consequences of HPV. “Protecting the immune system may prevent other diseases,” says Blackman.
More than 40 types of HPV can infect the genital areas and at least 15 of these types are considered “high risk,” meaning they can cause changes in cells that can lead to cancer. In the U.S., approximately 4,000 women die each year from cervical cancer, which almost always stems from HPV infection.
But HPV is very common — practically every sexually active person will acquire it at some point. In most cases, these infections do not lead to cancer, says Blackman, because a healthy immune system can normally clear the virus on its own. “But if your immune system is compromised, such as in HIV, you will not be able to fight off the infection,” she says. “Over time, persistent infection with HPV can lead to cancer.”
During the study, Blackman and her colleagues tested 176 HIV-positive women living in the Bahamas for the presence of high risk forms of HPV. They chose this population, she explains, because different strains of HPV are prominent in different geographic regions.
Around three-quarters of the women tested carried high-risk forms of HPV and approximately 30% had precancerous cervical cells, as well. The current vaccines for HPV prevent infections from 16, and 18, the most common types attributed to 70% of all cervical cancer world-wide. But Blackman and her colleagues found that many HIV-positive women living in the Bahamas who had precancerous cervical cells carried HPV types 16 and 18 but also had prominent infections with HPV types 52 and 58, which are high-risk but not protected by the current vaccines.